Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Peptide hydrogels show promise for healing skin, bone, and nerves but need improvement in stability and compatibility.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Targeted cancer therapies often cause serious skin problems that need careful management.

The model and estimator can predict drug exposure in kidney transplant patients well.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Some drugs can cause changes to your hair.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Nilotinib can cause keratosis pilaris, a skin condition.

Nilotinib can cause generalized keratosis pilaris.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.